Desentum Oy

Espoo, Central Finland, Finland desentum.fi

Overview

Desentum Oy is a biotechnology company based in Finland that focuses on developing novel immunotherapy treatments for allergies. Through innovative solutions targeting the immune system, the company aims to improve the quality of life for individuals suffering from allergic reactions.

Therapeutic areas

AllergyImmunotherapy

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Desentum Oy in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

ALK-Abelló A/S
Denmark
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Bial - Portela & Cª, S.A.
Portugal
Biomunex Pharmaceuticals
France
Biond Biologics Ltd.
Israel
Biontech Se
Germany

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo